UCLA Health’s Dr. Keith Vossel explains the science behind the newly approved drug Aduhelm
Constraining brain cells from sharing the disease-causing protein with neighboring cells slows the spread of damage
The test could eventually help provide more precise diagnoses for people with movement disorders such as Parkinson’s disease
Assessing and decreasing your fall risk
The new study examining how immune cells and neurons interact was led by researchers at the David Geffen School of Medicine at UCLA.
Neurologist Peter Goadsby will work with the UCLA Goldberg Migraine Program to expand inpatient treatment
The cases of Alzheimer's disease are growing rapidly in the U.S.
According to the latest data from the Centers for Disease Control and Prevention (CDC), there are close to 840,000 cases of traumatic brain injury (TBI) among children every year in the U.S. The groups most commonly at risk for brain injury are children age 0 to 4 and adolescents age [...]